List Results  
  Refine Search  
  Results by Topic  
  Results on Map  
  Search Details  
Found 48 studies with search of:   "Estramustine"
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Completed Safety and Efficacy Study of of Docetaxel vs Docetaxel Estramustine in Hormone Refractory Prostatic Cancer
Conditions: Hormone Resistant Prostate Cancer;   Metastatic Prostate Cancer
Interventions: Drug: docetaxel;   Drug: estramustine;   Drug: prednisone
2 Active, not recruiting Docetaxel, Estramustine and Short Term Androgen Withdrawal for Patients With a Rising PSA After Local Treatment
Conditions: Adenocarcinoma of the Prostate;   Prostate Cancer
Interventions: Drug: Docetaxel;   Drug: Estramustine;   Drug: Casodex;   Drug: Zoladex
3 Recruiting A Study of Epirubicin With Estramustine Phosphate and Celecoxib for the Treatment of Prostate Cancer
Condition: Prostate Cancer
Interventions: Drug: Epirubicin;   Drug: Estramustine Phosphate;   Drug: Celecoxib
4 Recruiting Combination of Docetaxel + Estramustine + Hydrocortisone Versus Docetaxel + Prednisone in Patients With Advanced Prostate Cancer
Condition: Prostatic Neoplasms
Interventions: Drug: Docetaxel + Estramustine + Hydrocortisone;   Drug: Docetaxel + Prednisone
5 Active, not recruiting Adjuvant Docetaxel and Estramustine Phosphate for High Risk Localized Prostate Cancer
Condition: Prostate Cancer
Interventions: Drug: Docetaxel;   Drug: Estramustine
6 Completed Estramustine, Docetaxel, and Carboplatin for Patients With Hormone Refractory Prostate Cancer Progressing After Mitoxantrone-Based Chemotherapy.
Condition: Prostate Adenocarcinoma
Interventions: Drug: Estramustine;   Drug: Docetaxel;   Drug: Carboplatin
7 Terminated Phase I/II Study of IV Estramustine Combined With Taxol in Patients With Hormone Refractory Adenocarcinoma of the Prostate
Condition: Prostate Cancer
Interventions: Drug: Estramustine;   Drug: Taxol
8 Active, not recruiting Weekly Paclitaxel, Low-Dose Estramustine, and Carboplatin in the Treatment of Hormone Refractory Prostate Carcinoma
Condition: Prostate Cancer
Interventions: Drug: Paclitaxel;   Drug: Estramustine;   Drug: Carboplatin
9 Active, not recruiting Oral Estramustine and Oral Vinorelbine in the Treatment of Hormone-Refractory Prostate Cancer
Condition: Prostate Cancer
Interventions: Drug: Oral Estramustine;   Drug: Oral Vinorelbine
10 Terminated Liposomal Doxorubicin and Estramustine Phosphate: Study in Taxane Resistant, Hormone Refractory Advanced Prostate Cancer
Condition: Prostate Cancer
Intervention: Drug: Doxil and Estramustine
11 Completed Estramustine and Paclitaxel in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy
Condition: Prostate Cancer
Interventions: Drug: estramustine phosphate sodium;   Drug: paclitaxel
12 Active, not recruiting Doxorubicin Plus Estramustine in Treating Patients With Metastatic Prostate Cancer
Condition: Prostate Cancer
Interventions: Drug: doxorubicin hydrochloride;   Drug: estramustine phosphate sodium;   Procedure: drug resistance inhibition treatment
13 Completed Estramustine, Docetaxel, and Carboplatin in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy
Condition: Prostate Cancer
Interventions: Drug: carboplatin;   Drug: docetaxel;   Drug: estramustine phosphate sodium
14 Active, not recruiting Docetaxel Combined With Estramustine in Treating Women With Metastatic Breast Cancer
Condition: Breast Cancer
Interventions: Drug: docetaxel;   Drug: estramustine phosphate sodium
15 Active, not recruiting Paclitaxel Plus Estramustine in Treating Patients With Metastatic Prostate Cancer
Condition: Prostate Cancer
Interventions: Drug: estramustine phosphate sodium;   Drug: paclitaxel
16 Active, not recruiting Docetaxel Plus Estramustine in Treating Patients With Metastatic Prostate Cancer
Condition: Prostate Cancer
Interventions: Drug: docetaxel;   Drug: estramustine phosphate sodium
17 Completed Paclitaxel Plus Estramustine in Treating Patients With Metastatic Prostate Cancer
Condition: Prostate Cancer
Interventions: Drug: estramustine phosphate sodium;   Drug: paclitaxel
18 Terminated Study of Paclitaxel, Estramustine Phosphate and Thalidomide for Patients With Metastatic Androgen-Independent Prostate Carcinoma
Condition: Prostate Cancer
Intervention: Drug: Thalidomide, Taxol, Estramustine
19 Active, not recruiting Paclitaxel and Estramustine in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
Condition: Lymphoma
Interventions: Drug: estramustine phosphate sodium;   Drug: paclitaxel
20 Completed Docetaxel, Estramustine, and Thalidomide in Treating Patients With Androgen-Independent Metastatic Adenocarcinoma of the Prostate
Condition: Prostate Cancer
Interventions: Drug: docetaxel;   Drug: estramustine phosphate sodium;   Drug: thalidomide

Previous Page Studies Shown (1-20) Next (21-40)
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services